Hinova Pharmaceuticals
Hinova Pharmaceuticals (688302.SH) is a clinical-stage biopharmaceutical company focused on the discovery and development of innovative targeted therapeutics and targeted protein degradation (PROTAC/molecular glue) drugs for oncology and autoimmune diseases.
Company Info
Sector:Biopharmaceuticals / Targeted Protein Degradation
Headquarters:Chengdu, China
Founded:2013
Website:http://www.hinovapharma.com/
Clinical Development Pipeline
HC-118 / EVO570
Target: Oral VAV1 Molecular Glue DegraderRecent News
No recent news updates available for this company.
Leadership Team
Dr. Yuanwei Chen
Chairman and CEO
Careers & Job Openings
No active job listings. Check back later.